Silobreaker.com    Log In
   My Page    Help   
360° SearchNetworkHot SpotsTrends
 
Advanced Search Options >>
Saturday, November 21, 2009 6:58 PM

Baxter International Inc

Baxter International Inc - Click to view 360-page
Baxter International Inc
Type: Company
Name: Baxter International Inc
First Reported 11/20/2009 - Updated 11/20/2009 - 3 Documents
European Union - Click to view 360-page
European Union
EU body backs single H1N1 vaccine dose
In a change of tack, Europe's drugs watchdog said today that giving a single dose of GlaxoSmithKline's Pandemrix or Novartis's Focetria swine flu vaccines would suffice for most people.The European Medicines Agency (EMEA) had previously said two doses ... [Irish Times - 11/20/2009]
First Reported 11/19/2009 - Updated 11/19/2009 - 3 Documents (in Medicine)
New Medicare Benefit to Provide Chronic Kidney Disease Patients with Education on Treatment Options
Baxter International Inc. (NYSE: BAX) commends the Centers for Medicare and Medicaid Services (CMS) on announcing implementation plans for a new Medicare benefit that will provide Stage 4 chronic kidney disease patients with coverage for up to six sessions ... [Pharmacy Choice - 11/19/2009]
First Reported 11/19/2009 - Updated 11/19/2009 - 1 Documents (in Biology)
Transplanting People's Own Stem Cells Into Heart Lessens Pain, Improves Ability To Walk
The largest national stem cell study for heart disease showed the first evidence that transplanting a potent form of adult stem cells into the heart muscle of subjects with severe angina results in less pain and an improved ability to walk. The transplant ... [Medical News Today - 11/19/2009]
First Reported 11/19/2009 - Updated 11/19/2009 - 1 Documents
Health Systems Pharmacy Product News
Baxter International Inc (Boston, MA) has announced the commercial launch of Hylenex recombinant (hyaluronidase human injection) for use in pediatric rehydration. An enzyme, Hylenex allows fluids to be administered subcutaneously rather than intravenously, ... [Pharmacy Times - 11/19/2009]
First Reported 11/20/2009 - Updated 11/20/2009 - 1 Documents
Prestigious awards for Baxter Healthcare
Mayo-based medical device company Baxter Healthcare walked away with the silver award in both the Manufacturing and Operational Excellence categories and Skills and Knowledge category at the third annual Irish Medical Devices Association (IMDA) Industry ... [Mayo Advertiser - 11/20/2009]
First Reported 11/20/2009 - Updated 11/20/2009 - 1 Documents
New York Stock Exchange - Click to view 360-page
New York Stock Exchange
TIM Report: Market Sentiment Still Bullish in U.S. but Down Globally
According to the recent TIM (Trade Ideas Monitor) report for the week of November 13-19, 2009, the TIM Sentiment Index (NYSE: TSI) increased 0.85 points to 55.29, staying within bullish territory (see$ last week's post$ and the$ youDevise website$ for ... [Green Faucet - 11/20/2009]
First Reported 11/17/2009 - Updated 11/18/2009 - 2 Documents (in Biology)
Treating heart disease with your own cells
The largest national stem cell study for heart disease showed the first evidence that transplanting a potent form of adult stem cells into the heart muscle of subjects with severe angina results in less pain and an improved ability to walk. The transplant ... [Scientist Live - 11/18/2009]
First Reported 11/17/2009 - Updated 11/18/2009 - 2 Documents (in Biology)
Heart therapy with stem cells shows progress
Northwestern University researcher Dr. Douglas Losordo using Baxter process to rebuild weak heartsXText SizeA treatment that uses adult stem cells to rebuild failing hearts reduced chest pain and improved activity levels for severely ill patients one ... [Chicago Tribune - 11/18/2009]
First Reported 11/18/2009 - Updated 11/18/2009 - 2 Documents
Report: Few women in key posts
Women in Chicago remain underrepresented in the top-ranking positions at Chicago's 50 largest public companies, according to the 12th annual Chicago Census from the Chicago Network, the women's professional organization that tracks the representation ... [Chicago Tribune - 11/18/2009]
First Reported 11/16/2009 - Updated 11/16/2009 - 2 Documents (in Market News)
Eight Recent Dividend Increases
Most investors believe that successful dividend investing consists of identifying the in the market and then generating double digit returns on investment each year. The problem with this strategy is that it often overlooks the fact that such dividend ... [Seeking Alpha - 11/16/2009]
First Reported 11/16/2009 - Updated 11/16/2009 - 2 Documents (in Biology)
Former Presidents George W. Bush, Bill Clinton to speak in Chicago next year
2010 biotech meeting lures former presidentsXText SizeTheir reported Radio City Music Hall showdown in New York may be off, but former Presidents George W. Bush and Bill Clinton are scheduled for a joint appearance to talk biotechnology next May in the ... [Chicago Tribune - 11/16/2009]
First Reported 11/14/2009 - Updated 11/14/2009 - 1 Documents (in Health)
Glaxo H1N1 Vaccine Approved - Zibb.com
Companies: Baxter International, Inc. (BAX), CSL Ltd. (CMXHF), GlaxoSmithKline plc (GSK), MedImmune, Inc. (MEDI), Novartis AG (NVS) GlaxoSmithKline plc (GSK) recently received approval from the U.S. Food and Drug Administration (FDA) for its unadjuvanted ... [Zibb - 11/14/2009]

Quotes

"For both vaccines, a single dose may be used in adults aged between 18 and 60 years and in children and adolescents, from the age of nine years for Focetria and from 10 years for Pandemrix the EMEA said in its latest statement following a monthly meeting of experts. Focetria and Pandemrix can be also been given at the same time as seasonal flu vaccines, it added. The updated position follows a review of the latest clinical data. In the case of Baxter International's Celvapan, however, the agency said that the data were still being assessed. LONDON, Nov 20 (Reuters) - In a change of tack, Europe's drugs watchdog said on Friday that giving a single dose of GlaxoSmithKline's Pandemrix or Novartis's Focetria swine flu vaccines would suffice for most people."
UPDATE 1-EU body backs single dose for 2 H1N1 flu vaccines [Interactive Investor International - 11/20/2009]
...participate in better management of their own care,' said James Sloand, M D , senior medical director of Baxter's North American Renal business. "This program empowers individuals to take measures to slow the progression of their kidney failure. It will also help patients prevent complications seen with chronic kidney disease, and enable them to proactively work with their physicians in determining which kidney replacement therapy is best suited to their health and lifestyle."
New Medicare Benefit to Provide Chronic Kidney Disease Patients with Education on Treatment Options [Pharmacy Choice - 11/19/2009]
...Researchers believe the loss of these blood vessels contributes to the pain of chronic, severe angina. "This is the first study to show significant benefit in pain reduction and improved exercise capacity in this population with very advanced heart disease" said principal investigator Douglas Losordo, M D , the Eileen M Foell Professor of Heart Research at the Northwestern University Feinberg School of Medicine...
Transplanting People's Own Stem Cells Into Heart Lessens Pain, Improves Ability To Walk [Medical News Today - 11/19/2009]
...on the risks of silicone breast implants was also ruled inadmissible in Hall v Baxter Healthcare, where the judge described her opinions as "no moremore than educated guesses dressed up in evening clothes." So far, no study has actually shown any causal evidence of the genital malformations and birth defects that, according to Swan, could be caused by phthalate...
Can Plastic Change Your Sex? [Forbes.com - 11/19/2009]

More Content

All (361) | News (311) | Reports (0) | Blogs (39) | Audio/Video (0) | Fact Sheets (11)
sort by: Date | Relevance
Swine flu update: Total infections down from la... [Irish Medical Times - 14 hours ago]
TIM Report: Market Sentiment Still Bullish in U... [Green Faucet - 11/20/2009]
EU body backs single H1N1 vaccine dose [Irish Times - 11/20/2009]
UPDATE 1-EU body backs single dose for 2 H1N1 f... [Interactive Investor International - 11/20/2009]
UPDATE 1-EU body backs single dose for 2 H1N1 f... [FinanzNachrichten.de - 11/20/2009]
Prestigious awards for Baxter Healthcare [Mayo Advertiser - 11/20/2009]
New Medicare Benefit to Provide Chronic Kidney ... [Pharmacy Choice - 11/19/2009]
Health Systems Pharmacy Product News [Pharmacy Times - 11/19/2009]
Transplanting People's Own Stem Cells Into Hear... [Medical News Today - 11/19/2009]
Can Plastic Change Your Sex? [Forbes.com - 11/19/2009]
Education program, bundled payments to improve ... [Chicago Tribune - 11/19/2009]
Improving care for dialysis patients [Chicago Tribune - 11/19/2009]
Treating heart disease with your own cells [Scientist Live - 11/18/2009]
Wall street Upgrades and downgrades [Financial News USA - 11/18/2009]
Report: Few women in key posts [Chicago Tribune - 11/18/2009]
Women in Chicago underrepresented in top jobs [Chicago Tribune - 11/18/2009]
Baxter India launches Recombinate therapy to tr... [PharmaBiz - 11/18/2009]
Upgrades & Downgrades: Toasting Bud With a ... [Minyanville - 11/18/2009]
BRIEF-RESEARCH ALERT-UBS raises Boston Scientif... [Forbes.com - 11/18/2009]
Heart therapy with stem cells shows progress [Chicago Tribune - 11/18/2009]
Your own stem cells can treat heart disease [Genetic Engineering News - 11/17/2009]
Stem cells show promise for heart patients [Chicago Tribune - 11/17/2009]
Caxton Associates 3Q 13F: Largest Eliminations [Morningstar UK - 11/17/2009]
Renaissance Technologies 3Q 13F: Largest ... [Morningstar UK - 11/17/2009]
US medical device tax would cost millions [Plastics and Rubber Weekly - 11/17/2009]
Re-evaluating the warnings of a 'feminista' nun [EnerPub - 11/17/2009]
An injection of H1N1 reason [National Post - 11/17/2009]
U.S. FDA advisory meetings through March 25 [London South East - 11/17/2009]
Research and Markets: Special Report: The Pande... [Forbes.com - 11/17/2009]
IA: Iowa will recover $1.2 milli... [Stateline - 11/17/2009]
1 2 3 4 5 6 7 8 9 10 ...
In Focus
  •  
Jon Kamp, Wayne Hockmeyer, Paul Price, [more]
  •  
New York Stock Exchange, Novartis AG, GlaxoSmithKline plc, [more]
  •  
Food and Drug Administration, World Health Organization, European Medicines Agency, [more]
  •  
Vaccine, Swine Flu Vaccine, Influenza A H1N1 Virus, [more]
  •  
Chicago, Boston (Massachusetts, United States), Washington DC, [more]
  •  
United States, Mexico, United Kingdom, [more]
  •  
Financial Reporting, Medicine, Internet & IT, [more]
  •  
Pharma & Biotech, Health, IT, [more]
Individual.com, Healthcare Sector and Stocks Analysis ..., RTTNews.com, [more]
Content Volume
Network
Trends

Blogs

sort by: Date | Relevance
November 2 2009: The American Dream needs a loan [The Automatic Earth - 11/03/2009]
Detroit Publishing Co. Rollin' on the river 1900The levee and the sternwheeler Falls City, Vicksburg, Mississippi Ilargi: After a weekend full of -pretty overwhelming- ...
Waiting it out [Spoonful of Medicine - Blog Posts - 10/29/2009]
The lines are long, and people have been turned away in droves. Only the lucky and persistent—including the Obama girls—have got their swine flu shots in the US. It’s ...
Baxter's key is versatility [BloggingStocks - 10/22/2009]
Filed under: Baxter Intl (BAX), Stocks to BuyAlthough Baxter International's (NYSE: BAX) shares have underperformed since the Buy rating on March 13, 2009 at a price ...
UPDATE 1-Australia’s CSL warns profit could fall [Economy-Finance - 10/13/2009]
* H1N1 vaccine production at maximum capacity * Shrugs off any plasma oversupply * Shares up 1.6 percent (Adds CEO comments) MELBOURNE, Oct 14 (Reuters) ...
Turnaround expert targets laggard pharmaceuticals [BloggingStocks - 10/12/2009]
Filed under: Newsletters, Abbott Laboratories (ABT), Baxter Intl (BAX), Bristol-Myers Squibb (BMY), Gilead Sciences (GILD), Stocks to Buy"Being contrarians, we are ...
1 2 3 4 5 6 7 8

  •  
  •  
  •